A. Whybro et al., PHOSPHATE SUPPLEMENTATION IN YOUNG MEN - LACK OF EFFECT ON CALCIUM HOMEOSTASIS AND BONE TURNOVER, European journal of clinical nutrition, 52(1), 1998, pp. 29-33
Objective: To examine the effect of phosphate supplements on calcium h
omeostasis and bone turnover in young men. Design: Study 1 was a rando
mised, controlled, cross-over trial of 1000 mg elemental phosphate giv
en for one week, with a standard diet of 800 mg/d each of calcium and
phosphorus. Study 2 was an escalating dose study of 0, 1000, 1500 and
2000 mg/d elemental phosphate, each given for one week, with a standar
d diet of 1000 mg/d each of calcium and phosphate. Setting: Northern G
eneral Hospital, Sheffield. Subjects: Study 1, 10 healthy men ages 19-
32 y. Study 2, 12 healthy men ages 19-38 y. Interventions: Sodium acid
phosphate tablets each containing 500 mg elemental phosphorus (16.1 m
mol/d), given with meals. Results: Study 1, administration of 32.2 mmo
l/d phosphorus resulted in a mean increase of 13.2 mmol/d urinary phos
phorus, a mean decrease of 1.1 mmol/d urinary calcium, and a mean incr
ease of 7 ng/mL in serum intact PTH. There were no changes in serum ph
osphate, osteocalcin or urinary N-telopeptide excretion. Study 2, admi
nistration of 64.4 mmol/d phosphorus resulted in a mean increase of 27
.2 mmol/d urinary phosphorus, a mean decrease of 2.4 mmol/d urinary ca
lcium, with no change in serum phosphate, PTH or urinary deoxypyridino
line. Conclusions: Phosphate supplementation of the diet does not affe
ct bone turnover in young men.